The lower rating reflects Integris’ sustained negative operations and S&P’s belief that the system’s balance sheet metrics will continue to weaken.
The rating outlook is stable.
More articles on healthcare finance:
Private equity pushes into healthcare: 8 latest deals
Moody’s: How CHS, Tenet and LifePoint are offsetting industry challenges
Amazon, Apple join growing list of companies opening on-site clinics for employees
